300 patients, advocates and researchers talk science, health disparities and filling in crucial data gaps at 'mets' conference
Sept. 26, 2017
| By Diane Mapes / Fred Hutch News Service
More than 300 metastatic breast cancer patients, researchers, advocates and caregivers gathered in Seattle over the weekend to discuss promising new therapies, patient-researcher partnerships, big data, advocacy, and, yes, cures.
Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers
Jan. 7, 2008
| By Kristen Woodward
Dr. Christopher Li and colleagues in Fred Hutchinson Cancer Research Center found that postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer.